[{"NetIncomeLoss_3_Q3_USD":-29799000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q3_shares":29323000.0,"WeightedAverageNumberOfSharesIssuedBasic_3_Q3_shares":29282000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":100000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":672600000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":1502000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":4100000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-1716000.0,"InventoryFinishedGoods_0_Q3_USD":41533000.0,"ProceedsFromCollectionOfNotesReceivable_3_Q3_USD":0.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q3_USD":900000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-39000.0,"StockRepurchaseProgramAuthorizedAmount1_0_Q3_USD":3800000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":114095000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":25328000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q3_USD":282000.0,"ProvisionForLoanLossesExpensed_3_Q3_USD":451000.0,"InsuranceRecoveries_3_Q3_USD":1600000.0,"InsuranceRecoveries_1_Q3_USD":1600000.0,"AssetsCurrent_0_Q3_USD":162927000.0,"Assets_0_Q3_USD":509823000.0,"CommonStockSharesIssued_0_Q3_shares":29323000.0,"UnrecognizedTaxBenefits_0_Q3_USD":900000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":118093000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":347657000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":150000000.0,"ContractWithCustomerLiability_0_Q3_USD":1100000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":451000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":15220000.0,"FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_3_Q3_USD":-11800000.0,"OtherNoncashIncomeExpense_3_Q3_USD":12000.0,"LongTermDebtCurrent_0_Q3_USD":0.0,"RestructuringSettlementAndImpairmentProvisions_3_Q3_USD":7881000.0,"LongTermDebt_0_Q3_USD":145051000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":0.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":49227000.0,"IncreaseDecreaseInReceivables_3_Q3_USD":-6178000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":3186000.0,"Liabilities_0_Q3_USD":305199000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-217000.0,"AccountsReceivableNetCurrent_0_Q3_USD":69577000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":72000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-11736000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":-1110000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-1110000.0,"RestructuringCosts_1_Q3_USD":2700000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-7226000.0,"RestructuringCosts_3_Q3_USD":12766000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":29323000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":29282000.0,"EarningsPerShareBasic_1_Q3_USD":-0.19,"EarningsPerShareBasic_3_Q3_USD":-1.02,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-350000.0,"InventoryRawMaterials_0_Q3_USD":26855000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":2562000.0,"RestructuringCosts_7_Q3_USD":30051000.0,"ShareBasedCompensation_3_Q3_USD":2584000.0,"CommonStockValue_0_Q3_USD":29000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_3_Q3_USD":13441000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":2248000.0,"OtherAssetsNoncurrent_0_Q3_USD":3573000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":6372000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-5111000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-28707000.0,"IncreaseDecreaseInInventories_3_Q3_USD":10468000.0,"RestrictedCash_0_Q3_USD":0.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":119400000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":0.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":2184000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.195,"ContractWithCustomerAssetNet_0_Q3_USD":10600000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":14808000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q3_USD":45100000.0,"ProceedsFromLinesOfCredit_3_Q3_USD":83000000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_1_Q3_USD":4401000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-10407000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":7643000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":23528000.0,"LegalFees_3_Q3_USD":1763000.0,"InterestExpense_3_Q3_USD":10326000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":9615000.0,"AccountsPayableCurrent_0_Q3_USD":56323000.0,"LiabilitiesCurrent_0_Q3_USD":125349000.0,"InventoryWorkInProcess_0_Q3_USD":8391000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29323000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29282000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":10600000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":797000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":297000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":12885000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-5715000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-37025000.0,"Goodwill_0_Q3_USD":69386000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":387000.0,"InterestExpense_1_Q3_USD":4178000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":2248000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":14323000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-7307000.0,"NetIncomeLoss_1_Q3_USD":-5498000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":168693000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q3_USD":99000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_3_Q3_USD":327000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1124000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":6608000.0,"LinesOfCreditCurrent_0_Q3_USD":41000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":1092000.0,"NumberOfOperatingSegments_3_Q3_segment":3.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":2248000.0,"AdditionalPaidInCapital_0_Q3_USD":164865000.0,"FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_3_Q3_USD":607000.0,"GrossProfit_1_Q3_USD":19689000.0,"GrossProfit_3_Q3_USD":56671000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":11186000.0,"LongTermDebtNoncurrent_0_Q3_USD":145051000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":11288000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":0.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":0.0,"EarningsPerShareDiluted_1_Q3_USD":-0.19,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":11218000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":509823000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":1595000.0,"InvestmentIncomeInterest_1_Q3_USD":13000.0,"InvestmentIncomeInterest_3_Q3_USD":31000.0,"InventoryNet_0_Q3_USD":76779000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q3_USD":387000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":2584000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3_Q3_USD":1092000.0,"OperatingIncomeLoss_3_Q3_USD":-14728000.0,"CommonStockSharesAuthorized_0_Q3_shares":50000000000.0,"DeferredFinanceCostsNet_0_Q3_USD":4949000.0,"TreasuryStockSharesAcquired_3_Q3_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":0.0,"LegalFees_1_Q3_USD":0.0,"OperatingIncomeLoss_1_Q3_USD":-793000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":4100000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":797000.0,"OperatingExpenses_3_Q3_USD":71399000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.02,"CommonStockSharesOutstanding_0_Q3_shares":29323000.0,"DeferredFinanceCostsCurrentNet_0_Q3_USD":1300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":1695000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3_Q3_USD":-1400000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":41446000.0,"InvestmentIncomeDividend_1_Q3_USD":281000.0,"DeferredFinanceCostsNoncurrentNet_0_Q3_USD":5000000.0,"InvestmentIncomeDividend_3_Q3_USD":844000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":404328000.0,"RestructuringAndRelatedCostExpectedCost1_0_Q3_USD":32000000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":150000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":11383000.0,"StockholdersEquity_0_Q3_USD":204624000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3761000.0,"OperatingExpenses_1_Q3_USD":20482000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":137782000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":1243000.0,"Ticker":"LNDC","CIK":"1005286","name":"LANDEC CORP CA","OfficialName":"Landec Corporation Common Stock (DE)","form":"10-Q","period":"20210228","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"306028744.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210408"}]